European Commission approves MenQuadfi®, the latest innovation in meningococcal (MenACWY) vaccination for individuals 12 months of age and older

European Commission approves Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older

Rilzabrutinib granted FDA Fast Track Designation for treatment of immune thrombocytopenia

FDA grants priority review for avalglucosidase alfa, a potential new therapy for Pompe disease

FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease

New clinical and health-related quality of life data in multiple myeloma and rare blood disorders to be presented at ASH 2020

Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products

Sanofi offers to acquire Kiadis for €308 million

European Patent Office rules in favor of Sanofi and Regeneron concerning Praluent® (alirocumab)

Sanofi Q3 2020 business EPS(1) growth of 8.8% at CER